ipsogen BCR-ABL1 Mbcr Kit CE
CE-IVD real-time PCR kit for p210 BCR-ABL1 transcript quantification in hematologic malignancies.
- Developer
- QIAGEN
- Intended use
- Monitoring, Mrd
- Cancer scope
- B-cell acute lymphoblastic leukemia, Chronic myeloid leukemia
- Specimen
- Bone marrow aspirate, Peripheral whole blood
- Molecular modality
- RNA
- Current version
- Current CE diagnostic p210 Mbcr b2a2/b3a2 configuration, cat. 670123/670125
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.